Mingyu Pan,Tongyu Hu,Jiao Lyu,Yue Yin,Jing Sun,Quanyi Wang,Lingxiao Xu,Haiyang Hu,Chen Wang,Mingyu PanTongyu HuJiao LyuYue YinJing SunQuanyi WangLingxiao XuHaiyang HuChen Wanga State Key Laboratory of Natural Medicines,School of Life Science and Technology,China Pharmaceutical University,Nanjing,Jiangsu,Chinab Department of Biomedical Science,City University of Hong Kong,Hong Kong,Hong Kong,Chinac Department of Rheumatology,The affiliated Suqian First People's Hospital of Nanjing Medical University,Suqian,Jiangsu,Chinad Department of Rheumatology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China

Abstract:STING1 (stimulator of interferon response cGAMP interactor 1) is the quintessential protein in the CGAS-STING1 signaling pathway, crucial for the induction of type I IFN (interferon) production and eliciting innate immunity. Nevertheless, the overactivation or sustained activation of STING1 has been closely associated with the onset of autoimmune disorders. Notably, the majority of these disorders manifest as an upregulated expression of type I interferons and IFN-stimulated genes (ISGs). Hence, strict regulation of STING1 activity is paramount to preserve immune homeostasis. Here, we reported that CSNK1A1/CK1α, a serine/threonine protein kinase, was essential to prevent the overactivation of STING1-mediated type I IFN signaling through autophagic degradation of STING1. Mechanistically, CSNK1A1 interacted with STING1 upon the CGAS-STING1 pathway activation and promoted STING1 autophagic degradation by enhancing the phosphorylation of SQSTM1/p62 at serine 351 (serine 349 in human), which was critical for SQSTM1-mediated STING1 autophagic degradation. Consistently, SSTC3, a selective CSNK1A1 agonist, significantly attenuated the response of the CGAS-STING1 signaling by promoting STING1 autophagic degradation. Importantly, pharmacological activation of CSNK1A1 using SSTC3 markedly repressed the systemic autoinflammatory responses in the trex1 -/- mouse autoimmune disease model and effectively suppressed the production of IFNs and ISGs in the PBMCs of SLE patients. Taken together, our study reveals a novel regulatory role of CSNK1A1 in the autophagic degradation of STING1 to maintain immune homeostasis. Manipulating CSNK1A1 through SSTC3 might be a potential therapeutic strategy for alleviating STING1-mediated aberrant type I IFNs in autoimmune diseases. Abbreviations: BMDMs: bone marrow-derived macrophages; cGAMP: cyclic GMP-AMP; CGAS: cyclic GMP-AMP synthase; HTDNA: herring testes DNA; IFIT1: interferon induced protein with tetratricopeptide repeats 1; IFNA4: interferon alpha 4; IFNB: interferon beta; IRF3: interferon regulatory factor 3; ISD: interferon stimulatory DNA; ISGs: IFN-stimulated genes; MEFs: mouse embryonic fibroblasts; PBMCs: peripheral blood mononuclear cells; RSAD2: radical S-adenosyl methionine domain containing 2; SLE: systemic lupus erythematosus; STING1: stimulator of interferon response cGAMP interactor 1; TBK1: TANK binding kinase 1.

Suppression of systemic autoimmunity by the innate immune adaptor STING

Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit Colitis

STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.

STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation

DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

Cutting Edge: DNA Sensing Via the STING Adaptor in Myeloid Dendritic Cells Induces Potent Tolerogenic Responses.

STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death

Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus

Activated STING in the thymus alters T cell development and selection leading to autoimmunity

Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes

Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115

STING an essential trigger of DNA-mediated innate immune signaling. (P1258)

Elucidating the function of STING in systemic lupus erythematosus through the STING Goldenticket mouse mutant

CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling

The transmembrane endoplasmic reticulum–associated E3 ubiquitin ligase TRIM13 restrains the pathogenic-DNA–triggered inflammatory response

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells

Cutting Edge: STING Mediates Protection Against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation

Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation

Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice